Form 4 for XERS Xeris Biopharma Holdings, Inc.
Accepted 2024-08-09 00:00:00 ET · period of report 2022-01-29 · accession 0001867096-24-000170 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-08-09 | 2022-01-29+ | XERS | Hecht Beth | See Remarks | F - Tax | $1.97 | -178.0K | 1.54M | -10% | -$350.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-29 | F | D | 14,037 | $2.11 | 1,544,771 | D | — | — | (F1) This transaction is being reported late due to administrative oversight. (F2) Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 29, 2022. (F3) These shares include 3,840 shares that were purchased on June 30, 2024 due to participation by the reporting individual in the issuer's 2018 Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2024-01-31 | F | D | 45,909 | $2.46 | 1,380,802 | D | — | — | (F1) This transaction is being reported late due to administrative oversight. (F10) Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 31, 2024. |
| 3 | Common | Common Stock | 2024-01-29 | F | D | 19,675 | $2.66 | 1,426,711 | D | — | — | (F1) This transaction is being reported late due to administrative oversight. (F9) Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 29, 2024. |
| 4 | Common | Common Stock | 2024-01-03 | F | D | 33,488 | $2.24 | 1,446,386 | D | — | — | (F1) This transaction is being reported late due to administrative oversight. (F8) Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 3, 2024. |
| 5 | Common | Common Stock | 2023-01-31 | F | D | 5,784 | $1.24 | 1,479,874 | D | — | — | (F1) This transaction is being reported late due to administrative oversight. (F7) Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 31, 2023. |
| 6 | Common | Common Stock | 2023-01-29 | F | D | 21,177 | $1.26 | 1,485,658 | D | — | — | (F1) This transaction is being reported late due to administrative oversight. (F6) Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 29, 2023. |
| 7 | Common | Common Stock | 2023-01-03 | F | D | 33,488 | $1.12 | 1,506,835 | D | — | — | (F1) This transaction is being reported late due to administrative oversight. (F5) Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 3, 2023. |
| 8 | Common | Common Stock | 2022-01-31 | F | D | 4,448 | $2.11 | 1,540,323 | D | — | — | (F1) This transaction is being reported late due to administrative oversight. (F4) Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 31, 2022. |